Questions about identifiabilityDear Silke,

 

When it comes to the structural observability/identifiability of your model I 
would recommend you to use the algorithm presented by Alexandre Sedoglavic in 
[1]. This algorithm tests local algebraic observability of a model structure of 
linear or rational functions if given in state-space form, i.e., as a set of 
ODEs with input and output signals. With this approach you can test the model 
structure if no etas or epsilons are considered (I'm not sure that it can be 
used in an accurate way with etas and epsilons).



Further on, the author of [1] has made an implementation of the algorithm in a 
major software (I'm not sure how touchy people in this forum are when it comes 
to talking about other software... ;-) so the effort of just trying it out is 
low. The implementation is provided on the homepage of the author.

 

Good luck!

 

/Martin

 

[1] Sedoglavic, A. "A probabilistic algorithm to test local algebraic 
observability in polynomial time". Journal of Symbolic Computation 33(5), pages 
735-755, 2002.



  ----- Original Message ----- 
  From: [EMAIL PROTECTED] 
  To: [EMAIL PROTECTED] 
  Sent: Friday, April 13, 2007 9:01 AM
  Subject: [NMusers] Questions about identifiability


  Dear NONMEM users, 

  The PK of the compound we are working on can be described by a 2-compartment 
model with non-linear protein binding in the central and in the peripheral 
compartment, which from a physiological point of view makes complete sense. The 
question we have is whether such model is identifiable having just total plasma 
concentration (no binding information is available).

  Therefore we want to simulate different kind of datasets and check if NONMEM 
is able to re-estimate them properly. 

    ·       Our first question was: "Is the structure itself in principle 
identifiable?"

            We simulated a dataset with 100 time points per subject and no 
intra- or inter-individual variability and no residual error. ('ideal' data: 
plenty      time points, no random error) Since under these conditions the 
parameters could be re-estimated (parameter estimates were nearly identical     
 to the original ones, %SE is very small) we concluded that the structure in 
principle is identifiable.

            

    ·       Our second question was: "Are the time points of the given study 
sufficient to estimate all parameters assuming 'ideal' data?" 

            We simulated the given dataset assuming no intra- or 
inter-individual variability and no residual error. The parameter estimates 
were again     nearly identical to the original ones and %SE is still very 
small (below 0.3 %).

    ·       Our third question was: "Could the parameters still be re-estimated 
if we assume inter- and intra-subject variability for the simulation step?"

            We simulated the given dataset assuming IIV, IOV and residual 
error. Under these conditions, the parameter (fixed and random effect)    
estimates are again similar, but not identical to the original ones, %SE 
increased to about  9% (one exception is the SE% of the parameter      for the 
amount of peripheral binding sites which were estimated to be 16%). However, 
when we re-estimate omitting the IIV and IOV, the  estimated parameters differ 
from the original ones and estimates for the peripheral binding becomes 
difficult to estimate.

  The questions we have are: 
  1.      Are these experiments sufficient to conclude on the model 
identifiability? 
  2.      Does it make sense that the fixed effect parameters differ from the 
original ones when IIV and IOV are omitted in the estimation step in constrast 
to when they are included in the simulation step? Shouldn't the structure of 
the model remain stable?

  3.      How often would you simulate and re-estimate the third experiment? 
  4.      Would you vary the initial estimates to check for any potential other 
set of parameters? (If yes how often?) 
  5.      One problem is that the complete model with IIV and IOV has quite 
long run times (around 24h), do you think checking the model with just IIV 
would be enough?

  6.      Do you have any other proposal to check for the identifiability of a 
model? 

  Your help is highly appreciated, thank you in advance, 

  Silke 




  Silke Dittberner 
  PhD student 
  Institute of Pharmacy 
  University Bonn 
  Germany 

Reply via email to